Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Brian Arciola"'
Autor:
Veit Bücklein, Ariel Perez, Kai Rejeski, Gloria Iacoboni, Vindi Jurinovic, Udo Holtick, Olaf Penack, Soraya Kharboutli, Viktoria Blumenberg, Josephine Ackermann, Lisa Frölich, Grace Johnson, Kedar Patel, Brian Arciola, Rahul Mhaskar, Anthony Wood, Christian Schmidt, Omar Albanyan, Philipp Gödel, Eva Hoster, Lars Bullinger, Andreas Mackensen, Frederick Locke, Michael von Bergwelt, Pere Barba, Marion Subklewe, Michael D. Jain
Publikováno v:
HemaSphere, Vol 7, Iss 8, p e907 (2023)
Real-world evidence suggests a trend toward inferior survival of patients receiving CD19 chimeric antigen receptor (CAR) T-cell therapy in Europe (EU) and with tisagenlecleucel. The underlying logistic, patient- and disease-related reasons for these
Externí odkaz:
https://doaj.org/article/96c7942628c54f0395c416764e463604
Autor:
Marion Subklewe, Veit Bücklein, Cecilia Carpio, Frederick L Locke, Andreas Mackensen, Dimitrios Mougiakakos, Michael von Bergwelt-Baildon, Pere Barba, Wolfgang Bethge, Kai Rejeski, Ariel Perez, Gloria Iacoboni, Olaf Penack, Liv Jentzsch, Grace Johnson, Brian Arciola, Viktoria Blumenberg, Eva Hoster, Lars Bullinger, Michael D Jain
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 5 (2022)
Externí odkaz:
https://doaj.org/article/400a6f8385c04652b2cf390c6b50b0b8
Autor:
Veit L Buecklein, Ariel Perez-Perez, Kai Rejeski, Gloria Iacoboni, Vindi Jurinovic, Udo Holtick, Olaf Penack, Soraya Kharboutli, Viktoria Blumenberg, Josephine Ackermann, Lisa Frölich, Grace Johnson, Kedar Patel, Brian Arciola, Christian Schmidt, Omar Albanyan, Philipp Gödel, Eva Hoster, Lars Bullinger, Andreas Mackensen, Frederick L. Locke, Michael von Bergwelt, Pere Barba, Michael D. Jain, Marion Subklewe
Publikováno v:
Blood. 140:2411-2413
Autor:
Ariel Perez, Grace Johnson, Kedar Patel, Brian Arciola, Anthony Wood, Christina A. Bachmeier, Julio C. Chavez, Bijal D. Shah, Farhad Khimani, Taiga Nishihori, Aleksandr Lazaryan, Marco L. Davila, Rahul Mhaskar, Frederick L. Locke, Sameh Gaballa, Michael D. Jain
Publikováno v:
Blood Advances. 6:3970-3973
Publikováno v:
Viral Drug Delivery Systems ISBN: 9783031205361
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7bec0a43bd31c105714dc27030ee3d9c
https://doi.org/10.1007/978-3-031-20537-8_11
https://doi.org/10.1007/978-3-031-20537-8_11
Autor:
Anthony C. Wood, Ariel Perez Perez, Brian Arciola, Kedar Patel, Grace Johnson, Elizabeth DiMaggio, Christina A. Bachmeier, Kayla Reid, Salvatore Carallo, Melanie H. Vargas, Rawan Faramand, Julio C. Chavez, Bijal Shah, Sameh Gaballa, Farhad Khimani, Hany Elmariah, Taiga Nishihori, Aleksandr Lazaryan, Ciara Freeman, Marco L. Davila, Frederick L. Locke, Rahul Mhaskar, Claude Bassil, Michael D. Jain
Publikováno v:
Transplantation and Cellular Therapy. 28:829.e1-829.e8
Patients with renal impairment (RI) are typically excluded from trials evaluating chimeric antigen receptor (CAR) T cell therapies. We evaluated the outcomes of patients with RI receiving standard of care (SOC) CAR T cell therapy for relapsed/refract
Autor:
Anthony C Wood, Brian Arciola, Kedar Patel, Grace Johnson, Ariel Perez Perez, Christina A Bachmeier, Elizabeth DiMaggio, Julio C. Chavez, Bijal Shah, Sameh Gaballa, Farhad Khimani, Taiga Nishihori, Aleksandr Lazaryan, Ciara Freeman, Marco L. Davila, Frederick L. Locke, Rahul Mhaskar, Claude Bassil, Michael D Jain
Publikováno v:
Transplantation and Cellular Therapy. 28:S194-S195
Autor:
Kai Rejeski, Ariel Perez, Gloria Iacoboni, Olaf Penack, Veit Bücklein, Liv Jentzsch, Dimitrios Mougiakakos, Grace Johnson, Brian Arciola, Cecilia Carpio, Viktoria Blumenberg, Eva Hoster, Lars Bullinger, Frederick L Locke, Michael von Bergwelt-Baildon, Andreas Mackensen, Wolfgang Bethge, Pere Barba, Michael D Jain, Marion Subklewe
Publikováno v:
Scientia
Hematologic neoplasms; Receptors; Chimeric antigen Neoplasias hematológicas; Receptores; Antígeno quimérico Neoplàsies hematològiques; Receptors; Antigen quimèric Background CD19-directed chimeric antigen receptor T-cell therapy (CAR-T) represe
Autor:
Rahul Mhaskar, Bijal D. Shah, Aleksandr Lazaryan, Sameh Gaballa, Marco L. Davila, Christina A Bachmeier, Michael D. Jain, Farhad Khimani, Taiga Nishihori, Julio C. Chavez, Anthony Wood, Frederick L. Locke, Kedar G. Patel, Brian Arciola, Grace Johnson, Ariel Perez Perez
Publikováno v:
Blood. 138:3855-3855
Introduction: Between 50-80% of patients with diffuse large B-cell lymphoma (DLBCL) are cured by frontline (1L) R-CHOP immunochemotherapy. Ultra-high risk (UHR) features for poor overall survival (OS) include: progression through the frontline therap
Autor:
Brian Arciola, Frederick L. Locke, Cecilia Carpio, Marion Subklewe, Pere Barba, Gloria Iacoboni, Michael von Bergwelt, Dimitrios Mougiakakos, Michael D. Jain, Andreas Mackensen, Ariel Perez-Perez, Olaf Penack, Kai Rejeski, Viktoria Blumenberg, Grace Johnson, Veit Buecklein, Eva Hoster, Liv Jentzsch, Lars Bullinger, Wolfgang Bethge
Publikováno v:
Blood. 138:3852-3852
Introduction: Prolonged cytopenias and infectious complications substantially contribute to the toxicity burden of CD19-directed CAR T-cell therapy (CAR-T). The latter represent the most common cause of non-relapse mortality after CAR-T. We have rece